US pharma major Johnson & Johnson has reported positive top-line Phase III data showing that a dual bispecific antibody ...
The European Medicines Agency’s (EMA) human medicines committee (CHMP) today announced recommendations for the approval of drugs at its July 2026 meeting. These will be passed for a final decision by ...
Spanish medical dermatology company Almirall (BME: ALM) has reported first-half 2026 net sales of 602.7 million euros ($687.1 ...
US president Donald Trump has set a countdown for tariffs on imported generic medicines, ending an exemption that had ...
UK gene therapy company EpilepsyGTx has named Teresa Nunes as its chief medical officer, tasking her with steering lead ...
A young California start-up wants to do for drug development what enterprise software did for accounting and sales: put the ...
Sanofi has announced changes to its executive committee, as the French pharma major streamlines senior leadership under chief ...
US pharma majors Gilead Sciences and Merck & Co have reported detailed Phase III data showing that their investigational once ...
US clinical-stage biotech Kairos Pharma saw its shares close down 12.6% at $0.31 yesterday, despite announcing a strategic ...
US immunology specialist Celldex yesterday reported mixed top-line results from the company’s Phase II study of barzolvolimab ...
Indian pharmaceutical stocks fell sharply on July 22 after US President Donald Trump announced plans to impose steep tariffs ...
Swiss contract development and manufacturing group Lonza today reported sales of 3.4 billion francs ($4.25 billion) in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results